Schneider Electric Korea (CEO Jiwoong Kwon), a global energy management and automation specialist, shares insights on accelerating the digital transformation of the bio and pharmaceutical industries with digital twin and robotics solutions.


Schneider will share insights on the digital transformation of the life science and pharmaceutical industries at the 9th Bio Forum Korea, held at Yangjae L Tower in Seoul on May 15.

This forum, hosted by Merck Life Science Korea, is a place to deeply discuss the impact of digital innovation on manufacturing processes and the direction of development in the rapidly growing pharmaceutical and bio markets.

In particular, an announcement highlighting the role of the Korea Bioprocessing Production Center scheduled to open in 2026 is also scheduled, attracting attention from industry experts.

Schneider Electric Korea's Manager Yoon-Guk Park (Automation Business Unit) will present at the forum on the topic of 'Digital Twin and Robotics Solutions Leading Digital Transformation in Life Sciences.'

Manager Park will introduce how digital technologies are transforming the biopharmaceutical industry, focusing in particular on how digital twin technology provides innovative performance within the industry.

Schneider Electric is We offer the EcoStruxure portfolio to support digitalization in the life sciences and pharmaceutical industries.

Among these, digital twin technology creates a virtual replica of a physical system, enabling real-time monitoring, simulation, data analysis, and optimization.

This will digitalize manufacturing processes to maximize operational efficiency and support data-driven management for regulatory compliance.

The EcoStruxure Machine Expert Twin solution enables productivity and operational efficiency through process digitalization, and supports consistent data-driven decision-making from design to execution and maintenance.

The forum will also feature Schneider Electric’s intelligent transport system, the Lexium MC12 Multi-Carrier.

This solution automates various logistics tasks within the production process, contributing to labor cost reduction and productivity improvement, and its flexible design makes it suitable for complex production environments in the life science and pharmaceutical industries.

Additionally, individual transport units can operate independently to efficiently handle a variety of products and packaging types, and in conjunction with robotic solutions, high-speed processing and precise logistics management are possible. Additionally, real-time status monitoring is possible by utilizing smart sensors and monitoring functions.

“The convergence of digitalization and automation solutions is a key element in maximizing production flexibility and shortening time to market, thereby enhancing the competitiveness of the pharmaceutical and bio industries,” said Park Yoon-kook, manager of Schneider Electric Korea. “Schneider Electric will lead the digital transformation of the industry through innovation strategies based on digital twin and robotics solutions.”

Meanwhile, Merck, which hosted this forum, is a leading science and technology company with 62,000 employees worldwide, and operates three business divisions: electronics, life sciences, and healthcare, with the goal of bringing positive changes to human life.